Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication201220132014201520162017201820192020202120222023202420252026 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyProduct Development Unit Sep 2025 Eur J Clin Microbiol Infect Dis Understanding phage Receptor-binding protein interaction with host surface receptor: the key for phage-Mediated detection and elimination of Pseudomonas aeruginosa Autoren Peng S et al. Sep 2025 BMJ Open Evaluating the diagnostic accuracy of WHO-recommended treatment decision algorithms for childhood tuberculosis using an individual person dataset: a study protocol Autoren Olbrich L et al. Sep 2025 Front Immunol HERV-K10 as a mediator of immune modulation in hepatitis infections Autoren Özer S et al. Sep 2025 Sci Rep Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study Autoren Heinrich F et al. Sep 2025 Mycoses Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States Autoren Reinhold I et al. Sep 2025 Emerg Infect Dis Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024 Autoren Baalmann F et al. Sep 2025 Lancet Infect Dis Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial Autoren Agnandji ST et al. Sep 2025 J Virol A novel accessory gene product of tick-borne Dhori-Orthomyxovirus, encoded by overlooked spliced transcripts of RNA segment 6 Autoren Bendl E et al. Sep 2025 Mucosal Immunol Akkermansia muciniphila ameliorates Salmonella-induced colitis and intestinal fibrosis Autoren Suwandi A et al. Sep 2025 Front Vet Sci On-site detection of MERS-CoV infections in a camel slaughterhouse in Kenya using a commercial rapid antigen test Autoren Ogoti BM et al. Sep 2025 Open Forum Infect Dis Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study Autoren Thompson GR et al. Sep 2025 mBio Aspergillus fumigatus effector crpA orchestrates host prostaglandin signaling to promote fungal virulence Autoren Pinzan CF et al. Sep 2025 Lancet Child Adolesc Health Childhood tuberculosis: robust funding and integrated solutions needed now Autoren Mandalakas AM Casenghi M Zwerling A Sep 2025 mBio Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024 Autoren Jeworowski LM et al. Sep 2025 PLoS One Whole blood RNA profiling in cats dissects the host immunological response during recovery from feline infectious peritonitis Autoren Zwicklbauer K et al. Sep 2025 Clin Microbiol Infect High rates of acquired resistance to fluoroquinolones, bedaquiline and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova Autoren Chesov D et al. Sep 2025 Z Gastroenterol Quality of life improves during antiviral therapy with bulevirtide Autoren Eichholz JC et al. Sep 2025 Mult Scler Severe course of tick-borne encephalitis (TBE) in a patient with relapsing multiple sclerosis (MS) treated with ocrelizumab Autoren Gernert JA et al. Sep 2025 J Ethnopharmacol Toxicity profile, antiplasmodial and gametocytocidal properties of Erigeron bonariensis L. (anc. Conyza bonariensis (L.) Cronquist) Autoren Lahngong MS et al. Sep 2025 New Microbes New Infect Tunnel sign on magnetic resonance imaging in neuromelioidosis: A systematic literature review Autoren Gupta N et al. Sep 2025 Bioinformatics TransFactor-prediction of pro-viral SARS-CoV-2 host factors using a protein language model Autoren An Y et al. Sep 2025 NPJ Biofilms Microbiomes Metatranscriptomics-based metabolic modeling of patient-specific urinary microbiome during infection Autoren Josephs-Spaulding J et al. Sep 2025 BMJ Open Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial) Autoren Rauber C et al. Sep 2025 BMC Public Health The interplay of influenza and COVID-19 in Germany, January 2020 - December 2022: a study of competitive disease dynamics with quarantine measures and partial cross-immunity Autoren Fome AD et al. Sep 2025 Inn Med (Heidelb) [Helicobacter pylori] Autoren Schulz C Schütte K Pagination Previous page ‹‹ Seite 27 Seite 28 Seite 29 Seite 30 Current page 31 Seite 32 Seite 33 Seite 34 Seite 35 Seite 27 Seite 28 Seite 29 Seite 30 Seite 31 Seite 32 Seite 33 Seite 34 Seite 35 Next page ››
Sep 2025 Eur J Clin Microbiol Infect Dis Understanding phage Receptor-binding protein interaction with host surface receptor: the key for phage-Mediated detection and elimination of Pseudomonas aeruginosa Autoren Peng S et al.
Sep 2025 BMJ Open Evaluating the diagnostic accuracy of WHO-recommended treatment decision algorithms for childhood tuberculosis using an individual person dataset: a study protocol Autoren Olbrich L et al.
Sep 2025 Front Immunol HERV-K10 as a mediator of immune modulation in hepatitis infections Autoren Özer S et al.
Sep 2025 Sci Rep Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study Autoren Heinrich F et al.
Sep 2025 Mycoses Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States Autoren Reinhold I et al.
Sep 2025 Emerg Infect Dis Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024 Autoren Baalmann F et al.
Sep 2025 Lancet Infect Dis Safety, tolerability, and protective efficacy of a radiation-attenuated, whole sporozoite malaria vaccine in children in Gabon: a randomised, double-blind, placebo-controlled, phase 2 trial Autoren Agnandji ST et al.
Sep 2025 J Virol A novel accessory gene product of tick-borne Dhori-Orthomyxovirus, encoded by overlooked spliced transcripts of RNA segment 6 Autoren Bendl E et al.
Sep 2025 Mucosal Immunol Akkermansia muciniphila ameliorates Salmonella-induced colitis and intestinal fibrosis Autoren Suwandi A et al.
Sep 2025 Front Vet Sci On-site detection of MERS-CoV infections in a camel slaughterhouse in Kenya using a commercial rapid antigen test Autoren Ogoti BM et al.
Sep 2025 Open Forum Infect Dis Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study Autoren Thompson GR et al.
Sep 2025 mBio Aspergillus fumigatus effector crpA orchestrates host prostaglandin signaling to promote fungal virulence Autoren Pinzan CF et al.
Sep 2025 Lancet Child Adolesc Health Childhood tuberculosis: robust funding and integrated solutions needed now Autoren Mandalakas AM Casenghi M Zwerling A
Sep 2025 mBio Humoral immunity to current variants of SARS-CoV-2 in exposed adults, September 2023 to September 2024 Autoren Jeworowski LM et al.
Sep 2025 PLoS One Whole blood RNA profiling in cats dissects the host immunological response during recovery from feline infectious peritonitis Autoren Zwicklbauer K et al.
Sep 2025 Clin Microbiol Infect High rates of acquired resistance to fluoroquinolones, bedaquiline and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of Moldova Autoren Chesov D et al.
Sep 2025 Z Gastroenterol Quality of life improves during antiviral therapy with bulevirtide Autoren Eichholz JC et al.
Sep 2025 Mult Scler Severe course of tick-borne encephalitis (TBE) in a patient with relapsing multiple sclerosis (MS) treated with ocrelizumab Autoren Gernert JA et al.
Sep 2025 J Ethnopharmacol Toxicity profile, antiplasmodial and gametocytocidal properties of Erigeron bonariensis L. (anc. Conyza bonariensis (L.) Cronquist) Autoren Lahngong MS et al.
Sep 2025 New Microbes New Infect Tunnel sign on magnetic resonance imaging in neuromelioidosis: A systematic literature review Autoren Gupta N et al.
Sep 2025 Bioinformatics TransFactor-prediction of pro-viral SARS-CoV-2 host factors using a protein language model Autoren An Y et al.
Sep 2025 NPJ Biofilms Microbiomes Metatranscriptomics-based metabolic modeling of patient-specific urinary microbiome during infection Autoren Josephs-Spaulding J et al.
Sep 2025 BMJ Open Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial) Autoren Rauber C et al.
Sep 2025 BMC Public Health The interplay of influenza and COVID-19 in Germany, January 2020 - December 2022: a study of competitive disease dynamics with quarantine measures and partial cross-immunity Autoren Fome AD et al.
